I know that the news today can be overwhelming, even just mentioning the word facts can trigger all sorts of reactions.

I'm Dr. Michael Greger and I've been to really like facts, so I devoted my life to learning all there is to know about the latest nutrition research so that you and your family can lead healthier or productive lives.

Today, back by popular demand, we present the nutrition facts grab back with the latest news on a whole variety of topics.

First up, some dietary approaches to female sexual dysfunction.

The creation and promotion of female sexual dysfunction as a mental disorder seems like a textbook case of disease monitoring by the pharmaceutical industry,

and harkening back to the first DSM, psychiatry's diagnosis manual, which listed fragidity as a mental disorder along, of course, with homosexuality.

The latest manifestation is hypoactive sexual desire disorder, a disease invented by drug companies.

As like when Prozac was about to go off patent, the company sponsored the creation of a new mental illness to market a drug called Seraphim, which was simply Prozac repacked in a pink capsule.

The condition previously known as shyness was branded as social anxiety disorders so they could get kids on paxle.

There are certainly women who are troubled by low libido, but there's no reliable scientific evidence that hypoactive sexual desire disorder is a real medical condition.

And women can get diagnosed with it even with a normal libido.

A woman highly interested in sex, just not for whatever reason with her current partner, can still qualify for the diagnosis and the drug.

Even a woman who is perfectly satisfied with her sex life may still qualify if her partner isn't.

Our story begins in 2009 when a drug company tried to get a failed antidepressant called the flabancerin, approved to treat hypoactive sexual desire disorder.

The only problem, it didn't work.

It was resubmitted again after more study and was still rejected as was the appeal.

But in 2015, the FDA approved the drug.

What changed nothing about its efficacy, it didn't work any better.

What changed is that the drug company that bought it helped launch an astroturfake grassroots advocacy group even the score, which lobbied for approval under a feminist rubric.

Men have their drugs, why don't women get any sex drugs, which was exposed as kind of a bitter irony.

But hey, within 48 hours of FDA approval, the drug was sold for a cool billion in cash, very satisfying for the drug company.

But what about the women who take the drug?

...